Adaptation of the Uniform Data Set for Telematic Administration
Harmonization and Updating of Cognitive and Behavioral Assessment Procedures in Neurology: Adaptation of the Uniform Data Set for Telematic Administration
1 other identifier
interventional
14
1 country
1
Brief Summary
The present project is an evolution of the previous RIN 2019 study aimed at validating and standardizing the Uniform Data Set (UDS) for dementia, a battery of tests exploring various cognitive domains (memory, language, praxis, executive functions) and involving partial tablet-based computerization for data collection. In the present study, a UDS-based instrument that can be used in remote examiner-assisted telematic administration will be validated. This will be followed by standardization of the same on a sample of healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedFirst Submitted
Initial submission to the registry
March 2, 2023
CompletedFirst Posted
Study publicly available on registry
March 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 19, 2025
September 1, 2025
5 months
March 2, 2023
September 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
concordance index
Measure the concordance index in the administration of individual battery tests between in-person and computer-based administration
from baseline through study completion, an average of 1 year and a half
Secondary Outcomes (1)
regression lines
from baseline through study completion, an average of 1 year and a half
Study Arms (1)
Normal subjects
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- female and male subject between 50 and 90 years
- no negative score on the Anamnestic Questionnaire
- internist pathology in pharmacological compensation
- signing of informed consent
You may not qualify if:
- neurological pathologies
- decompensated metabolic pathology
- use of Benzodiazepine and psychoactive drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Clinica della memoria
Rome, Lazio, 00168, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Camillo Marra, MD
Memory clinic, Fondazione Policlinico Gemelli, IRCCS, Università Cattolica del Sacro Cuore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2023
First Posted
March 27, 2023
Study Start
September 14, 2021
Primary Completion
January 31, 2022
Study Completion
December 1, 2025
Last Updated
September 19, 2025
Record last verified: 2025-09